The 14th US-Japan Cellular and Gene Therapy Conference Agenda

on
Induced Pluripotent Stem Cells (iPS): Derivation and Characterization

Natcher Conference Center
Building 45, Balcony A and B, National Institutes of Health
Bethesda, Maryland 20892

Thursday, February 24, 2011

---

The conference is jointly supported by the Center for Biologics Evaluation and Research (CBER), US Food and Drug Administration (FDA) and the Ministry of Education, Culture, Sports, Science and Technology, Japan under the US-Japan Cooperative Research Program. The goal of this conference is to exchange ideas on cutting edge areas of biomedical research and to enhance opportunities for collaborations among scientists from the US and Japan. The scientific theme of our joint annual meetings has been diverse. We have invited speakers from Japan and the US to discuss advances in this emerging field of research and highlight FDA's regulations in this cutting-edge field of biomedical research.

Seating is limited to 200 attendees and is on a first-come-first-served basis. No prior registration is required. For more information, please contact Dr. Syed R Husain by e-mailing syed.husain@fda.hhs.gov or phone at (301) 827-0475.

---

Program

---

8:00 a.m. – 8:30 a.m.	Registration Coffee and Breakfast
Moderator	Syed Husain, Senior Staff Scientist, Division of Cellular and Gene Therapies, CBER, US Food and Drug Administration, Bethesda, Maryland
8:30 a.m. – 8:35 a.m.	Opening Remarks Carolyn Wilson, Associate Director of Research, CBER, US Food and Drug Administration, Bethesda, Maryland
8:35 a.m. – 8:40 a.m.	Yoshikazu Ohya, Professor, Department of Integrated Biosciences Graduate School of Frontier Sciences, University of Tokyo, Japan

---

AM Session

---

Moderators	Yoshikazu Ohya, Professor, Department of Integrated Biosciences Graduate School of Frontier Sciences, University of Tokyo, Japan Steven Bauer, Chief, Cellular and Tissue Therapy Branch, Division of Cellular and Gene Therapies, CBER, FDA, Bethesda, Maryland
8:40 a.m. – 9:10 a.m.	Generation of Platelets from Pluripotent Stem Cells Hiromitsu Nakauchi, Professor and Director, Division of Stem Cell Therapy, Center for Stem Cell and Regenerative Medicine, Institute of Medical Science, University of Tokyo, Tokyo
9:10 a.m. – 9:40 a.m.	A Comprehensive Comparison of Induced Pluripotent Stem Cells to Human Embryonic Stem Cells Barbara Mallon, NIH Stem Cell Unit, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, Maryland
9:40 a.m. – 10:10 a.m.	Lessons from Developmental Biology to Generate Functional Liver Cells from iPS Cells Atsushi Miyajima, Professor and Director, Institute of Molecular and Cellular Biosciences, University of Tokyo, Tokyo

---

10:10 a.m. – 10:40 a.m.	Coffee Break

---

10:40 a.m. – 11:10 a.m.	Human iPS Cells Derived from Blood Cells by a Non-integrating Plasmid Linzhao Cheng, Co-Director, Institute for Cell Engineering Stem Cell Program; Department of Medicine Division of Hematology, Johns Hopkins University School of Medicine, Baltimore, Maryland
11:10 a.m. – 11:40 a.m.	Perspectives on Pluripotent Stem Cell-based Therapies: Regulatory and Scientific Issues Steven Bauer, Chief, Cellular and Tissue Therapy Branch, Division of Cellular and Gene Therapies, CBER, FDA, Bethesda, Maryland

---

11:40 p.m. – 1:00 p.m.	Lunch

---

PM Session

---

Moderators	Ricardo Feldman, Associate Professor, Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland Hiromitsu Nakauchi, Professor and Director, Division of Stem Cell Therapy, Center for Stem Cell and Regenerative Medicine, Institute of Medical Science, University of Tokyo, Tokyo
1:00 p.m. – 1:30 p.m.	Design of Cell-recognizable Nanobiomaterials for ES/iPS Cells Proliferation and Hepatocyte Differentiation: Concept of Cell Cooking Plate for Regenerative medicine Toshihiro Akaike, Professor, Graduate School of Bioscience and Biotechnology, Department of Biomolecular Engineering, Tokyo Institute of Technology, Tokyo
1:30 p.m. – 2:00 p.m.	Generation of Patient-specific Induced Pluripotent Stem Cells for Modeling and Treating Gaucher Disease Ricardo Feldman, Associate Professor, Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland
2:00 p.m. – 2:30 p.m.	Application of iPS Cell Technology for NKT Cell-targeted Adjuvant Therapy for Tumors in Mice Haruhiko Koseki, Group Director, RIKEN Research Center for Allergy and Immunology, Yokohama

---

2:30 p.m. – 3:00 p.m.	Coffee Break

---

3:00 p.m. – 3:30 p.m.	iPS Cell Research for Cardiovascular Regeneration Jun Yamashita, Associate Professor, Laboratory of Stem Cell Differentiation, Institute for Frontier Medical Sciences, Kyoto University
3:30 p.m. – 4:00 p.m.	New Insights on Genomic Stability and Immortality of Pluripotent Stem Cells Michal Zalzman, Visiting Fellow, Developmental Genomics and Aging Section, Laboratory of Genetics, National Institute on Aging, Baltimore, Maryland
4:00 p.m. – 4:30 p.m.	Generation of Induced Pluripotent Stem Cells from Human Peripheral Blood: Less Invasive and Clinically Applicable Technique Shinsuke Yuasa, Professor, Department of Regenerative Medicine and Advanced Cardiac Therapeutics, Keio University School of Medicine, Tokyo

---

Thank you for your participation!

---

Organizers:	Syed R Husain, Ph.D. Raj K Puri, M.D., Ph.D. Tumor Vaccines and Biotechnology Branch Division of Cellular and Gene Therapies NIH Bldg. 29B, Room 2G07, HFM-735 Bethesda, Maryland, 20892 Ph. 301-827-0475; Fax 301-827-0449 syed.husain@fda.hhs.gov raj.puri@fda.hhs.gov	Yoshikazu Ohya, Ph.D. Professor, Division of Biosciences Department of Integrated Biosciences Graduate School of Frontier Sciences University of Tokyo Bldg. FSB-101, 5-1-5 Kashiwanoha Kashiwa, Chiba Prefecture 277-8562 Japan ohya@k.u-tokyo.ac.jp